Tirzepatide is an engineered 39-amino acid peptide with a structure based on the GIP sequence, achieving long-acting properties through a C20 fatty acid side chain
Combined L-citrulline supplementation and slow velocity low-intensity resistance training improves leg endothelial function, lean mass, and strength in hypertensive postmenopausal women
Retatrutide's triple receptor activity creates a more complex pharmacological picture than single-agonist GLP-1s, and individual factors including your current dose, your side effect history, your training schedule, your sleep patterns, and any concurrent medications all shape what the right timing looks like for your specific situation
N Engl J Med (2019) 380(4):34757
Investigators have studied the compound across cell-type-specific exposures, biomaterial-integrated delivery formats, and combination protocols with adjacent research compounds